Starpharma Holdings Limited (ASX:SPL) Directors Insider Transactions
The Directors and Chief Executives of Starpharma Holdings Limited (ASX:SPL) are required by law to report any insider transaction activities i.e. buying, selling, option exercising the Starpharma Holdings Limited's shares in the stock market. Below table shows the list of insider transactions as reported by Starpharma Holdings Limited to the ASX stock exchange.
An insider trade occurs when an individual (such as a CEO, CFO or COO) that has non-public information about a company buys or sells shares of that company's stock. Tracking a company's insider trades is a metric that can be used to identify the direction that the company's executives believes that the company is headed. For example, if a number of insiders purchase more shares of a company, they may believe that the company will have strong future earnings and that the share price will increase in the near future.
Starpharma Holdings Limited Directors/Insider Transactions Activity
List of Insider trades activity from Starpharma Holdings Limited (SPL).
| Date | Director | Director's Title | Shares | Value | Note |
|---|---|---|---|---|---|
| 11 Aug 2026 | Basser (Russell) | Independent Non-Executive Director | 36,191 | 14,432 | Other at price 0.40 per share. |
| 11 Aug 2026 | Cheng (Lynda) | Independent Non-Executive Director | 22,741 | 9,069 | Other at price 0.40 per share. |
| 11 Aug 2026 | Davies (Jeff) | Independent Non-Executive Director | 117,291 | 46,775 | Other at price 0.40 per share. |
| 11 Aug 2026 | Maley (Cheryl) | Chief Executive Officer | 16,667 | 6,646 | Other at price 0.40 per share. |
| 11 Aug 2026 | Maley (Cheryl) | Chief Executive Officer | 0 | - | Other at price 0.40 per share. |
| 11 Aug 2026 | Thomas (Robert Bain) | Independent Non-Executive Director | 350,001 | 139,580 | Other at price 0.40 per share. |
| 16 Oct 2025 | Thomas (Robert Bain) | Independent Non-Executive Chairman | 450,000 | 81,315 | Purchase at price 0.18 per share. |